网站大量收购独家精品文档,联系QQ:2885784924

lung cancer screening 2019taking global implementation forward肺癌筛查进行全球实施.pptx

lung cancer screening 2019taking global implementation forward肺癌筛查进行全球实施.pptx

  1. 1、本文档共44页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多

LungCancerScreening:

Takingglobalimplementationforward

HarryJ.deKoning,MDPhDProfessorofPublicHealthScreeningEvaluationDeputyHeadDepartmentofPublicHealthErasmusMC,Rotterdam,theNetherlands

Conflictsofinterest

TheNELSONtrialissupportedby:SiemensGermanyprovidedworkstationsforuniformreadinginNELSONRocheDiagnosticsprovidedfundsforaside-studyonproteomicsNELSONPerceptronixprovidedfundsforasputumsidestudy(withseparateconsent)Departmentreceived/receivesresearchfundsfromNIH,EU,OntarioandSwissresearchfundsregardingLCcontrolNopersonalconflictsofinterestIwillnotdiscussofflabeluseand/orinvestigationaluseinmypresentation

100days

immuno-200days200daysLungcancer10.5years(3,800days)200daysCTscanLC

In:EuropeanGuideonQualityImprovementinComprehensiveCancerControl(2017)byTitAlbreht,R.KiasuwaM.vandenBulckeThestep-wisedecision-makingconcerningpotentialnewcancerscreeningprogrammesincludetheestablishmentofevidenceofeffectiveness,benefitsthatoutweightheharms,andcost-effectiveness.

SensitivityofCT-LCScreeningbyhistologyandstageCXRsensitivity:2.51%-97.31%CTsensitivity:8.83%-99.35%CT:3-foldhighersensitivityfordetectinglungcancerstageItenHaafetal.,CEBP2015

TheNationalLungScreeningTrialResearchTeam.NEnglJMed2011;365:395-409.CumulativeNumbersofLungCancersandofDeathsfromLungCancerNLST

?CISNETModelaverage1950cohortSHG1,followedfromages45-90(Annals2014)MISCAN-LungSHG2Full1950cohort,followedfromages55-100(newruns)MISCAN-LungSHG2Evereligibles1950cohort,followedfromages55-100(newruns)Proportioneverscreened**19.3%21.5%97.9%Benefits(per100,000)???Personsnolongerdyingoflungcancer4979014,200Life-yearsgained5,25011,74654,538LYG/deathprevented10.613.013.0Lungcancermortalityreduction14.0%17.7%30.9%Harms(per100,000)???TimespersonsundergoCTscreening

文档评论(0)

158****9376 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档